Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
IN VIVO ANTIGENIC TARGETS OF T...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
IN VIVO ANTIGENIC TARGETS OF T CELLS INDUCED BY ADENOVIRAL VECTORED VACCINES IN PATIENTS WITH CHRONIC HCV INFECTION
Bibliographic Details
Main Authors:
Kelly, C
,
Folgori, A
,
Capone, S
,
Brown, A
,
Swadling, L
,
Townsend, R
,
Halliday, J
,
Stafford, E
,
O'Donnell, D
,
Naddeo, M
,
Collier, J
,
Adams, D
,
Colloca, S
,
Traboni, C
,
Cortese, R
,
Nicosia, A
,
Klenerman, P
,
Barnes, E
Format:
Conference item
Published:
2012
Holdings
Description
Similar Items
Staff View
Similar Items
A THERAPEUTIC VACCINE FOR HCV BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
by: Kelly, C, et al.
Published: (2011)
A highly immunogenic novel genetic vaccine against HCV
by: Del Sorbo, M, et al.
Published: (2012)
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
by: Swadling, L, et al.
Published: (2014)
PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES
by: Folgori, A, et al.
Published: (2009)
Highly immunogenic virally vectored T-cell vaccines cannot overcome subversion of the T-cell response by HCV during chronic infection
by: Swadling, L, et al.
Published: (2016)